Category: Kezar
-
US FDA puts Kezar Life Sciences’ lupus treatment trial on hold after patient deaths By Reuters
•
(Reuters) – The US Food and Drug Administration imposed a clinical suspension on the drug Kezar Life Sciences (NASDAQ:)’ trial of an experimental drug for lupus, the company said Friday. The FDA’s decision comes after the company said it had temporarily halted a mid-stage trial of the drug, zetomipzomib, to…